Generic Semaglutide: Lower-Cost Semaglutide is Here!
BUY NOW
We Ship To The U.S. Only
Retatrutide Cost Breakdown
Estimated Monthly Price, Coverage & Discounts
- Posted On:
- 19 Jun, 2026
- 12 min read
-
Mounjaro (Tirzepatide): A once-weekly injectable medication for adults with type 2 diabetes or obesity.Starting From $559.99
10% Off On Your First Order
Click on the Copy Code button to copy your code.
No Expiry
Exclusive On Duty Free Meds Only
- Mounjaro (Tirzepatide): A once-weekly injectable medication for adults with type 2 diabetes or obesity.Starting From $559.99
10% Off On Your First Order
Click on the Copy Code button to copy your code.
No Expiry
Exclusive On Duty Free Meds Only
- Many patients struggling with type 2 diabetes and obesity are anticipating the upcoming release of retatrutide
- This medication is still undergoing clinical trial testing
- Retatrutide has already seen strong early results in comparison with other similar medications (like Wegovy and Mounjaro)
- Pricing still has not been finalized since retatrutide does not yet have FDA approval, but it is estimated at $1,000-$1,500 per month
- Market trends can be used to give patients an idea of what pricing will look like when it comes out
What Is Retatrutide?
Retatrutide is an upcoming medication that is currently being studied to help patients with issues like weight loss and metabolic conditions. It may also be potentially used for type 2 diabetes management. Retatrutide works similarly to current popular brands like Wegovy and Zepbound. It functions by imitating hormones that the body naturally produces. However, the main difference between this medication and other current name brands is that it works like three different hormones instead of one or two. This medication targets GIP and GLP-1 hormones, as well as glucagon receptors.
Phase 2 trials for this medication showed that patients taking the two highest doses of retatrutide (8 mg and 12 mg) – which were gradually increased from a starting dose of 2 mg – lost about 24% of their body weight in 48 weeks. This high effectiveness and triple action will likely cause the eventual price to be higher than the currently approved medications.
Retatrutide Cost Breakdown
The price that retatrutide will likely be can be estimated based on the current list prices of other similar medications. Wegovy’s current list cost comes in at about $1,350 for a month’s supply and the current list price for Zepbound is about $1,086 for a month’s supply. Mounjaro also has a list price of about $1,080 for a monthly supply of the medication. This information indicates that the list price of retatrutide will likely be at least about $1,000-$1,500 per month.
| Medication | Cost For a Month’s Supply |
|---|---|
| Wegovy | ~$1,350 |
| Zepbound | ~$1,086 |
| Mounjaro | ~$1,080 |
| Retatrutide (Estimated) | ~$1,000 to $1,500+ |
This medication may cost even more since it will be a new medication that is manufactured by a trusted company – Eli Lilly and Company – and may be more effective than the other medications (as indicated in the trials so far). Higher demands can also lead to higher costs. The same goes for whether this medication is widely covered by insurance and how complex its manufacturing is.
Why Retatrutide Will Likely Be Expensive
Obesity drugs like retatrutide are usually expensive in the U.S. for many different reasons. One of the main reasons is that there is always a high demand for these types of medications – especially with data showing about 37% of the adult population are considered to be obese. This specific medication would also mark the release of the first triple-agonist drugs into the market. This minimizes the drug’s competition and allows the company to charge higher prices.
There is also a high research and development cost associated with these types of medications. These costs and the cost of commercializing the medication are also often factored into the price that will be charged to patients. It is common for GLP-1 medications to start off by being listed for premium prices of at least $1,000 per month or more – especially when they are new and before generic versions are launched.
Factors That Will Influence Your Cost
There are also some more personal factors that can influence the cost of the medication once it comes out. Many patients may not receive coverage if the medication is strictly being used for obesity treatment. This is because drug coverage is much more limited for obesity treatment than it is for type 2 diabetes treatments. Whether or not a patient gets coverage for the medication and how much that coverage may be depends on the specific insurance plan that they have and the formulary decisions.
The amount the patient will have to spend on their medication also depends on the pharmacy they plan to purchase it from. It is oftentimes cheaper for patients to mail-order their medications – especially if they buy multiple months’ worth of medication at a time or buy from cheaper pharmacies in areas like Canada.
Some patients may also owe more money for their medication as their dose is increased over time – as larger pens often cost more. However, there are many instances now where a flat rate is charged for medication doses. Availability of coupons and savings programs to patients after the medication’s release can also impact the total price of the medication.
Will Insurance Cover Retatrutide?
Coverage for retatrutide may vary depending on the individual’s insurance plan when it launches. Patterns with similar medications – like Wegovy and Zepbound – show that there are better coverage options for diabetes medications. This is especially the case since Affordable Care Act insurance plans are not technically required to cover obesity medications. However, some still do cover these medications. Workplace insurance is seeming to be shifting more towards covering GLP-1 benefits overall. Medicare still usually does not cover weight loss medications and Medicaid coverage for these types of medications varies by state.
Expected Savings and Coupon Programs
Patients may still have some other coverage options once the medication comes out. Patients who do have commercial insurance that covers it may be able to get copay cards to greatly reduce the cost of the medication. They may be able to apply for these cards on the manufacturer’s website or by asking a doctor or pharmacist for further details. GLP-1 medications (like Mounjaro and Wegovy) often reduce the patient’s out-of-pocket costs to closer to $25 to $100 per month if they get approved – with a maximum of up to $1,250 per month.
Some patients that meet certain financial need criteria may also be able to apply for patient assistance programs (if any cover this medication once it comes out) to help them get access to the medication. Lilly Cares Foundation offers this assistance for many medications based on what patients’ household income is in comparison to the Federal Poverty Line (starting for those 300% below this level) and how many members live in that household. This program is usually only available to patients without insurance coverage. Novo Nordisk also has this type of program available for those starting at 400% below the FPL. Applicable patients could get their medication costs fully covered under this program.
Comparing The Cost of Retatrutide With Other GLP-1 Medications
How to Save on Retatrutide When It Becomes Available
Pricing for this medication has not yet been finalized. However, patients can already start planning ahead for ways to cut down the cost once it officially hits the market.
- Reviewing Insurance Plan Coverage
Patients who plan to purchase this medication should first check their insurance formulary once the medication has been released. Some insurers may require prior authorization or proof of medical necessity before approving coverage – especially if this medication is being used for managing weight. - Manufacturer Savings Programs
Eligible patients could significantly lower their monthly costs if Eli Lilly releases copay cards or savings programs for retatrutide – similar to what they offer for Mounjaro and Zepbound. Commercially insured patients often see their copays reduced to somewhere between $25 and $100 per month when these programs are available. - Considering Canadian or International Pharmacy Options
Many patients may find more affordable options through international pharmacies and prescription fulfillment services – particularly those based in Canada – once retatrutide becomes more available globally. Patients can often save up to 80% on their prescription medications when they order from these options. - Looking Into Telehealth Weight-Management Programs
Some patients also may be able to turn to telehealth services to help find more affordable options for purchasing their medication once it is released. This applies to patients who may not even be covered by insurance.
FAQs
How much will retatrutide cost per month?
Retatrutide is expected to cost somewhere about $1,000 to $1,500 per month. These numbers are based on the pricing of similar GLP-1 medications. The final price will not be confirmed until FDA approval.
Will retatrutide be more expensive than Mounjaro or Wegovy?
It most likely will be since it is a new triple-agonist medication and early studies show potentially greater effectiveness compared to current options.
Will insurance provide coverage for retatrutide when used for weight management?
Coverage will vary by insurer. Many plans cover GLP-1 medications for type 2 diabetes. However, coverage for weight loss is much more limited.
Will there be a savings card at launch?
Most likely. Eli Lilly typically offers copay cards for new medications – especially for patients with commercial insurance.
Can I buy it from Canada when released?
This medication should be available for purchase in Canada once retatrutide becomes available internationally. Ordering from licensed places in Canada can be a great way for uninsured patients to save money on their prescriptions.
Is retatrutide available yet?
No. Retatrutide is still undergoing clinical trials and does not yet have FDA approval.
The Bottom Line
It is likely that retatrutide will fall within the same high-cost category as other GLP-1 medications once the medication is released. However, pricing and coverage details will become clearer closer to the date of approval. Patients should make sure to stay updated and speak with healthcare providers about future options.
Purchase more affordable prescription medications online today – including weight loss medications – at Duty Free Meds.
Sources
Disclaimer: The information presented here is intended solely for educational purposes and should not be interpreted as medical advice, a diagnosis, or specific treatment recommendations. It does not imply endorsement of any particular medication or therapy. Health conditions and treatment responses can differ significantly between individuals; thus, this information is not a guarantee of safety, suitability, or effectiveness for anyone in particular. Always seek the guidance of a healthcare professional for personalized medical advice and consult them before making any health or treatment decisions.
